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An  l-rhamnose-binding  lectin  named  ELEL  was  isolated  from  eggs  of the  rock  boring  sea urchin  Echinome-
tra  lucunter  by  afﬁnity  chromatography  on  lactosyl-agarose.  ELEL  is  a homodimer  linked by  a disulﬁde
bond  with  subunits  of  11  kDa  each. The  new  lectin  was inhibited  by  saccharides  possessing  the  same  con-
ﬁguration  of hydroxyl  groups  at C-2 and  C-4, such  as l-rhamnose,  melibiose,  galactose  and lactose.  The
amino acid  sequence  of  ELEL  was  determined  by  tandem  mass  spectrometry.  The ELEL subunit  has  103
amino  acids,  including  nine  cysteine  residues  involved  in four  conserved  intrachain  disulﬁde  bonds  andectin
ass spectrometry
arine invertebrate
hamnose
lobotriaosylceramide
one interchain  disulﬁde  bond.  The  full  sequence  of  ELEL  presents  conserved  motifs  commonly  found  in
rhamnose-binding  lectins,  including  YGR,  DPC  and  KYL.  A three-dimensional  model  of  ELEL  was  created,
and  molecular  docking  revealed  favorable  binding  energies  for interactions  between  ELEL  and  rhamnose,
melibiose  and  Gb3 (Gal1-4Gal1-4Glc1-Cer).  Furthermore,  ELEL  was  able  to  agglutinate  Gram-positive
bacterial  cells,  suggesting  its ability  to recognize  pathogens.. Introduction
Rhamnose-binding lectins (RBLs) belong to a group of lectins
hat bind speciﬁcally to l-rhamnose and -galactose, rather than
-galactosides, and do not require divalent cations or thiol groups
or their hemagglutinating activity [1,2]. Many RBLs are composed
f repeated carbohydrate recognition domains (CRD), containing
bout 95 amino acid residues each and a unique / fold with long
tructured loops important for monosaccharide recognition [3,4].
hese lectins share four conserved disulﬁde bonds and two  con-
erved motifs: -ANYGR(TD)- in N-terminal and -DPCX(G)T(Y)KY(L)-
n C-terminal, which are involved in the primary recognition of
igands [4–6].
∗ Corresponding author at: BioMar-Lab, Departamento de Engenharia de Pesca,
niversidade Federal do Ceara, Av. Mister Hull, 60440-970, Box 6043, Fortaleza,
eara, Brazil. Tel.: +55 85 33669728; fax: +55 85 33669728.
E-mail address: alexholandasampaio@gmail.com (A.H. Sampaio).
ttp://dx.doi.org/10.1016/j.ijbiomac.2015.03.072
141-8130/© 2015 Elsevier B.V. All rights reserved.©  2015  Elsevier  B.V.  All  rights  reserved.
The biological function of RBLs is not yet known. However,
it is likely that these lectins play a role in the production of
reactive oxygen species and phagocytosis, regulation of carbo-
hydrate metabolism, prevention of polyspermy and self-defense
[7–9]. Members of the RBL family act as pattern recognition
receptors (PRRs), recognizing various pathogen-associated molec-
ular patterns (PAMPs). RBLs can recognize lipopolysaccharides
and lipoteichoic acid, constituents of cell wall of Gram-positive
and Gram-negative bacteria, respectively, thus acting as opsonins
[10–12].
Structurally, RBLs can be divided into ﬁve subfamilies. Type I
possesses three repeated domains, and Type II is composed of two
repeated domains with an extra domain. Type III and Type IV have
two repeated domains, but they have different sugar speciﬁcity.
Finally, Type V has only one domain able to form a homodimer
with a disulﬁde bond between subunits [3].Most RBLs studied have been found in ﬁsh eggs and ovaries.
However, the ﬁrst RBL described, the sea urchin eggs lectin, or SUEL,
was puriﬁed from eggs of the sea urchin Anthocidaris crassispina
[13,14]. Also, RBLs have been described in colonial ascidians and
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ivalves [12,15]. Interestingly, SUEL is unique member of the Type
 subfamily.
The rock boring sea urchin Echinometra lucunter Linnaeus is
ommonly found throughout the Caribbean Sea and South Amer-
ca coast. It commonly occurs on coral reefs and shallow rock areas
here depths reach 2 m.  Great populations of E. lucunter can con-
ribute greatly to the breakdown of coral reefs as a consequence of
heir burrowing behavior. E. lucunter is therefore considered a pest
n many countries, including Brazil [16].
In this work, we report the puriﬁcation, amino acid sequenc-
ng and structure prediction of a new RBL from E. lucunter eggs,
amed ELEL (E. lucunter eggs lectin). Based on structural data, the
nteraction of ELEL with carbohydrates was tested by molecular
ocking.
. Materials and methods
.1. Animal collection and extract preparation
Specimens of the rock boring sea urchin E. lucunter were col-
ected at Pacheco Beach, Caucaia, Ceará State, Brazil. The animals
ere transported to the laboratory in a thermal box containing sea
ater.
E. lucunter eggs were obtained by coelomic injection of 0.5 M
Cl. The eggs were dejelled by several washes in acidic seawater,
H 5.0. Dejelled eggs were defatted by treatment with cold acetone.
fter three exchanges of acetone, eggs become colorless.
Colorless eggs were suspended in ﬁve volumes of TBS (Tris-
uffered saline, 150 mM NaCl, 0.1 mM PMSF, 50 mM Tris–HCl, pH
.6) and sonicated in ice 10 times at 70 W for 50 s at intervals of
 min  using a Bandelin SONOPULS HD 2070 sonicator. The mixture
as centrifuged at 5000 × g for 20 min  at 4 ◦C. The supernatant was
amed crude extract and was assayed for hemagglutinating activity
nd protein concentration [17].
.2. Puriﬁcation of E. lucunter eggs lectin
The crude extract was loaded on a lactosyl-agarose column
1.0 cm × 3.0 cm), previously equilibrated with TBS. The column
as washed with the same buffer at a ﬂow rate of 1 mL/min until the
olumn efﬂuents showed absorbance of less than 0.01 at 280 nm.
he adsorbed lectin was eluted with 0.3 M l-rhamnose in TBS. 1-mL
ractions were manually collected, dialyzed and freeze-dried until
se.
.3. Hemagglutinating activity and hemagglutination inhibitory
ssay
Lectin activity was estimated by hemagglutinating activity
gainst a solution of 3% rabbit and human erythrocytes (A, B and
) in native form and treated with proteases. The hemagglutina-
ion tests were performed in microtiter plates with V-bottom wells
sing the two-fold serial dilution method [18].
A hemagglutination inhibition assay was performed using
he standard procedure [18]. The following carbohydrates
nd glycoproteins were used: d-fructose, d-galactose, d-
lucose, d-mannose, l-rhamnose, methyl--d-galactopyranoside,
ethyl--d-galactopyranoside, N-acetyl-d-galactosamine, N-
cetyl-d-glucosamine, N-acetyl-d-mannosamine, d-sucrose,
-melibiose, -lactose, -lactose, orosomucoid, ovomucoid,
hyroglobulin and porcine stomach mucin (PSM). The initial con-
entrations of the inhibitors were 100 mM for sugars and 2 mg/mL
or glycoproteins.
The effects of pH, temperature, EDTA and divalent cations on
ectin activity were evaluated as described by Sampaio et al. [18].gical Macromolecules 78 (2015) 180–188 181
2.4. Molecular mass and sugar content of ELEL
Molecular mass of ELEL under denaturing condition was
estimated by SDS–PAGE in the presence and absence of -
mercaptoethanol, followed by staining with Coomassie Brilliant
Blue, as described by Laemmli [19]. LMW-SDS Marker kit (GE
Healthcare) was used as the standard (phosphorylase b (Mr:
97,000), albumin (Mr: 66,000), ovalbumin (Mr: 45,000), carbonic
anhydrase (Mr: 30,000), trypsin inhibitor (Mr: 20,100) and -
lactalbumin (Mr: 14,400).
Glycoproteins in SDS–PAGE were stained with periodic acid-
Schiff (PAS), as described by Zacharius et al. [20]. Neutral sugar
content in ELEL was  evaluated by phenol-sulfuric acid, using lactose
as the standard [21].
The relative mass of native ELEL was  estimated by gel ﬁltration
on a BioSuite 250 5 m HR SEC (0.78 cm × 30 cm)  column coupled
to the H-Class Bio Acquity UPLC System (Waters Corp.). The col-
umn  was  equilibrated with 50 mM Tris–HCl, pH 7.2, containing
500 mM NaCl, and calibrated with conalbumin (75 kDa), ovalbumin
(45 kDa), carbonic anhydrase (29 kDa), ribonuclease A (13.7 kDa)
and aprotinin (6.5 kDa).
The molecular mass of ELEL was determined by ElectroSpray
Ionization-Mass Spectrometry (ESI-MS). Puriﬁed lectin (6 mg/mL)
was solubilized in 8 M Urea and submitted to reverse phase
chromatography (RPC) on a Sephasil Peptide C-8 10/250 column
coupled to the H-Class Bio Acquity UPLC System (Waters Corp.).
The column was  equilibrated with 5% ACN in 0.1% triﬂuoracetic acid
(TFA) and eluted with a gradient of acetonitrile (ACN) in 0.1% TFA.
Fractions containing ELEL were collected and directly infused into a
nanoelectrospray source coupled to a Synapt HDMS ESI-Q-ToF mass
spectrometer (Waters Corp.). The instrument was calibrated with
[Glu1]- Fibrinopeptide B fragments. Mass spectra were acquired by
scanning at m/z ranging from 1000 to 4000 at 5 scans/s. The mass
spectrometer was operated in positive mode, using a source tem-
perature of 363 K and capillary voltage at 3.2 kV. Data collection and
processing were controlled by Mass Lynx 4.1 software (Waters).
2.5. Primary structure determination by tandem mass
spectrometry (MS/MS)
ELEL was submitted to SDS–PAGE as described above. After
staining, ELEL spots were excised, reduced with dithiothreitol
(DTT), and carboxyamidomethylated with iodoacetamide (IAA), as
described by Shevchenko et al. [22].
Treated spots were subjected to digestion with the follow-
ing enzymes: trypsin, chymotrypsin and pepsin. Digestions with
trypsin and chymotrypsin were realized in 50 mM ammonium
bicarbonate at 1:50 w/w  (enzyme/substrate). Digestion with pepsin
was performed in 0.1 M HCl at 1:50 w/w (enzyme/substrate). All
digestions were maintained at 37 ◦C for 16 h.
The digestions were stopped with 2 L of 2% formic acid (FA).
The peptides were extracted from the gel conform, as described
by Shevchenko et al. [22]. Two microliters of the peptide solution
were loaded onto a C-18 (0.075 × 100 mm)  nanocolumn coupled
to a nanoAcquity system (Waters Corp.). The column was  equili-
brated with 0.1% FA and eluted with an ACN gradient in 0.1% FA. The
eluates were directly infused into a nanoelectrospray source. The
mass spectrometer was operated in positive mode with a source
temperature of 373 K and a capillary voltage at 3.0 kV. LC–MS/MS
was performed according to the data-dependent acquisition (DDA)
method. The lock mass used in acquisition was m/z 785.84 ion
of the [Glu1]- Fibrinopeptide B. The selected precursor ions were
fragmented by collision-induced dissociation (CID) using argon as
collision gas. All of the CID spectra were manually interpreted. A
search for similar sequences was performed using the online tool
1 f Biological Macromolecules 78 (2015) 180–188
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Fig. 1. SDS–PAGE (15%) of puriﬁed ELEL. (M)  Molecular marker; (1) 40 g of
T
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LASTp. Leucine and isoleucine were assigned according to their
imilarity with other lectins.
.6. Agglutination of bacterial cells
Escherichia coli and Staphylococcus aureus were grown in nutri-
nt broth at 37 ◦C for 24 h and harvested by centrifugation at
000 × g for 10 min. Bacterial count was calculated by the serial
ilution method, and absorbance at 625 nm was maintained around
.0. Agglutination assays were performed as described by Melo et al.
23].
.7. Molecular modeling by homology of ELEL
The structures were predicted through the homology molecular
odeling server I-TASSER [24], a free online program that allows a
rotein structure to be fully modeled by homology. The template
sed to obtain the model of ELEL-1 was the crystal structure of
he rhamnose-binding lectin CSL-3 (PDB ID: 2ZX2), which had the
ighest degree of identity among the primary structures aligned
ith ELEL-1. All model quality parameters were analyzed at the
nd of computational simulation.
.8. Molecular docking
The model ELEL-1 structure obtained by structural homol-
gy was used for all docking simulations. The three-dimensional
tructures of potential ligands were drawn using the online soft-
are PRODRG [25]. The carbohydrates used were l-rhamnose and
elibiose and a glycolipid (globotrioseceramide; Gal1-4Gal1-
Glc1-Cer). Molecular docking analysis was performed with
olegro using the MolDock method [26]. MolDock is based on a
earch algorithm combining differential evolution with a cavity
rediction algorithm. The program takes hydrogen bond direction-
lity into account as an additional term in the docking scoring
unction. A re-ranking procedure was added to increase docking
ccuracy. A MolDock Score (MDS) was calculated using the scor-
ng function. Grid resolution was 0.30 A˚ with radius of 15 A˚. The
earch algorithm used was MolDock Optimizer with default set-
ings. The number of runs was 10, and the maximum number of
nteractions was 2000. The population size and maximum number
f poses were 200 and 10, respectively. Protein–ligand interaction
nergy was expressed in the form of the MDS  in arbitrary units. A
ore negative value reﬂects a stronger interaction. The MDS  was
alculated with the following equation: MDS  = Einter + Eintra, where
inter is the ligand–protein interaction energy [26].
inter =
∑
i∈ligand
∑
j∈ligand
[
EPLP(rij) + 332.0
qjqj
4rij2
]
. Results.1. Puriﬁcation of ELEL
The crude extract of E. lucunter eggs showed strong hemag-
lutinating activity against rabbit and human erythrocytes. After
able 1
uriﬁcation procedure of ELEL.
Fraction Protein total (mg) HU/mL Speciﬁc activit
(HU/mg) 
Crude extract 80.9 32 19.7 
Afﬁnity column 2 32 561.4 
a Minimum concentration able to cause hemagglutination.ELEL  in the absence of reducing agents; (2) 40 g of ELEL in the presence of -
mercaptoethanol.
afﬁnity chromatography on the lactosyl-agarose column, unad-
sorbed material was devoid of hemagglutinating activity, whereas
adsorbed proteins, recovered with 0.3 M l-rhamnose, concentrated
most of the hemagglutinating activity of the crude extract.
SDS–PAGE analysis of the adsorbed proteins revealed one
unique band of 22 kDa and 14 kDa in the absence and presence of
reducing agents, respectively (Fig. 1). E. lucunter eggs lectin (ELEL)
appears to be a dimeric protein formed by two subunits linked by
a disulﬁde bond. ELEL was puriﬁed 28 times and represented 70%
of the total hemagglutinating activity of the extract (Table 1).
3.2. Sugar binding speciﬁcity of ELEL
ELEL was  able to agglutinate human and rabbit erythrocytes
with a slight preference for rabbit erythrocytes treated with trypsin.
Hemagglutinating activity of ELEL was, however, inhibited by sev-
eral sugars, including galactose, lactose, rhamnose and melibiose
(Table 2). l-rhamose was the most potent inhibitor for ELEL with
minimum inhibitory concentration (MIC) of 0.4 mM.  Glycoproteins,
such as mucin and thyroglobulin, showed no inhibition at concen-
trations up to 2 mg/mL.
y Yeld
(%)
Puriﬁcation (fold) MACa (g/mL)
Total
1600 100 1 50
1120 70 28.4 1.8
R.F. Carneiro et al. / International Journal of Biolo
Table  2
Inhibition of the hemagglutinating activity of ELEL by sugars and glycoproteins.
Sugars MIC*
d-Arabinose –
l-Fucose –
d-Galactose 12.5 mM
d-Glucose –
d-Mannose –
l-Rhamnose 0.39 mM
N-acetyl-d-galactosamine –
N-acetyl-d-glucosamine –
N-acetyl-d-mannosamined-Xylose – –
Methyl--d-galactopyranoside 12.5 mM
Methyl--d-galactopyranoside 12.5 mM
d-Maltose –
d-Sucrose –
-d-Lactose 1.56 mM
-d-Lactose 1.56 mM
-d-Melibiose 0.78 mM
Glycoproteins
Orosomucoid –
Thyroglobulin –
Ovomucoid –
Porcine stomach mucin –
* Minimum concentration of sugar required for inhibition.
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Based on hemagglutinating assays, the interaction between
F
H.3. Effects of pH, temperature and divalent cations
Divalent cations and EDTA did not affect ELEL activity (Fig. 2A).
he optimum pH for ELEL activity was 7. Below this value, the activ-
ty was stable up to pH 4. Above pH 7, hemagglutinating activity
ecreased until it was abolished at pH 10 (Fig. 2B). ELEL showed
elative thermal stability, maintaining its total activity up to 60 ◦C.
fter that, activity decreased slightly until it was  entirely lost at
00 ◦C (Fig. 2C).
.4. Molecular mass and sugar content
The molecular mass of native ELEL was estimated to be 26 kDa
y size exclusion chromatography. RPC revealed heterogeneities
n ELEL preparations. Two isolectins (ELEL-1 and ELEL-2) could be
artially separated by RPC on a C8 column (Fig. 3). On ESI-MS,
LEL-1 showed a molecular mass of 22,091 ± 2 Da, whereas ELEL-
 showed a molecular mass of 23,286 ± 2 Da (Fig. 4). These ions
epresent dimeric forms of ELEL-1 and ELEL-2. Estimated mass of
he monomeric forms of ELEL-1 and ELEL-2 were 11,045 ± 2 Da and
1,643 ± 2 Da, respectively.
No sugar contents were found in ELEL by the phenol-sulfuric
cid method, and no coloration was observed when SDS–PAGE was
ncubated with periodic acid Schiff. These results indicated that
LEL is not a glycoprotein.
ig. 2. Properties of the hemagglutinating activity of ELEL. Effect of divalent cations and
emagglutinating activity was expressed in logarithm scale as units of titter.gical Macromolecules 78 (2015) 180–188 183
3.5. Primary structure of ELEL
Because of the low yield of isoform 2 in soluble form, only ELEL-
1 was sequenced. Its N-terminal was  blocked and thus could not be
determined by Edman degradation. Peptides sequenced by MS/MS,
corresponding to the N-terminal region, presented a blocked ter-
minal amino group, with all peptides having pyroglutamic acid as
the ﬁrst residue in this region, whereas the unblocked peptides had
glutamic acid in the N-terminal (Supplementary table).
De novo sequencing revealed a polypeptide chain of 103 residues
with a combined molecular mass of 11,047 Da. This value is
in good agreement with molecular mass determined by ESI-MS
(11,045 ± 2 Da).
The amino acid sequence of ELEL-1 is shown in Fig. 5. Nine half-
cysteines were found; eight appear to be involved in intrachain
disulﬁde bonds, whereas one half-cysteine forms a disulﬁde bond
between two subunits to link the homodimer. No glycosylation site
was found. Microheterogeneities were observed in four positions:
26 (K/R); 64 (N/Q); 91 (H/L); and 99 (T/S).
A homolog search with BLASTp demonstrated that the ELEL-1
sequence was signiﬁcantly similar to RBLs of other invertebrates
(Fig. 6), such as sea urchin eggs lectin from A. crassispina (61%), pre-
dicted RBL from the sea urchin Strongylocentrotus purpuratus (45%),
RBL from the Paciﬁc oyster Crassotrea gigas (47%) and predicted
RBL from Hydra vulgaris (48%). Moreover, ELEL-1 showed relative
identity with CSL3 (43%), an RBL isolated form chum salmon eggs
(Oncorhynchus keta).
3.6. Agglutination of bacterial cells
ELEL (100 g/mL) could agglutinate Gram-positive formalin-
killed S. aureus,  but was not able to agglutinate Gram-negative E.
coli (Fig. 7).
3.7. Molecular modeling by homology of ELEL-1
The model of ELEL-1 resulted in a C-score of 1.56. A high-quality
model is expected to have strongly positive C-scores (−5 to 2). TM-
score of 0.93 ± 0.06 and RMSD of 1.2 ± 1.2 A˚ indicate that the model
obtained by homology showed excellent quality [24,27]. The ELEL-
1 model consists of 103 amino acids folded as a -sandwich. The
structure has two  anti-parallel -sheets with two (2 and 4) and
three (1, 3, and 5) strands, two helices (1–2), and six loop
regions (Fig. 8), from which loops 1, 5 and 6 comprise residues that
are part of the CRD.
3.8. Molecular dockingELEL-1 and mono- (l-rhamnose) and disaccharide (melibiose) was
calculated. We  also determined the interaction with the glycolipid
 EDTA (A), pH (B) and temperature (C) on the hemagglutinating activity of ELEL.
184 R.F. Carneiro et al. / International Journal of Biological Macromolecules 78 (2015) 180–188
Fig. 3. Reverse phase chromatography of ELEL. Sephasil C-8 column was equilibrated and washed with 5% ACN in 0.1% TFA. Elution was  performed with ACN gradient in 0.1%
TFA.  Flow rate was  maintained at 1.0 mL/min.
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IFig. 4. Molecular mass determination of ELEL. Mass sp
b3 (Gal1-4Gal1-4Glc1-Cer) present on the surface of both
acrophages and some tumor cells.
Carbohydrates were anchored in the region corresponding to
RD of ELEL-1 and presented scores of −54.94 MDS  and −112.74
DS  for l-rhamnose and melibiose, respectively.
ELEL-1 molecular docking performed with Gb3 showed favor-
ble binding energy with MDS  at −143.99 (Fig. 9A) and revealed
hat Gb3 interacts with amino acids Glu15, Asp48, Gly49, Ala50,
sp86, Met89, His90, Trh91, Tyr92, and Lys93 through hydrogen
onds and van der Waals interactions (Fig. 9B).
. DiscussionSince Ozeki and coworkers reported the ﬁrst known RBL [14],
everal RBLs have been isolated and characterized from roes and
varies of teleosts [1,11,28,29] and marine invertebrates [12,15,30].
ig. 5. Amino acid sequence of ELEL-1. Peptides originated by different digestions are re
soleucine.of ELEL after RPC, using nano ESI infusion at 1 L/min.
In this work, we have isolated an l-rhamnose-binding lectin, named
ELEL, from the eggs of the rock boring sea urchin E. lucunter by afﬁn-
ity chromatography on lactosyl-agarose. Since all lectin activity
presented in the crude extract was  totally recovered by adsorp-
tion onto immobilized lactose, the use of lactosyl-agarose to purify
the lectin proved to be successful. Afﬁnity chromatography is a
standard procedure for isolation of RBLs, such as lectins from Pte-
ria penguin [12], Ctenopharyngodon idellus ovaries [31], Plecoglossus
altivelis eggs [32], Silurus asotus roe [33], and Botryllus schlosseri
[15].
Actually, the protein isolated from E. lucunter eggs is a mixture
of two isolectins. MS  analysis revealed a slight difference between
the molecular masses of ELEL-1 and ELEL-2. The microhetero-
geneities found in four positions of the amino acid sequence of ELEL
could be attributed to inter-individual variations. Unfortunately,
these small differences could not be detected by SDS–PAGE or size
presented by T (trypsin), Q (chymotrypsin) and P (pepsin). X represents Leucine or
R.F. Carneiro et al. / International Journal of Biological Macromolecules 78 (2015) 180–188 185
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sig. 6. Comparison of amino acid sequence of ELEL-1 to invertebrate RBLs and CS
ELEL-1), A. crassispina eggs RBL (SUEL), Crassostreagigas predicted RBL – domain 1(C
ileolus RBL – domain 1 (TpRBL-1), H. vulgaris predicated RBL – domain 1 (HvRBL-1
xclusion chromatography, nor could a successful separation of
LELs be performed by RPC. Therefore, in biological assays and
iochemical characterization, ELEL preparations were considered
 unique protein.
The presence of isoforms in RBL preparations is relatively com-
on  and has already been described in the Japanese catﬁsh S.
sotus [33] and the ponyﬁsh Leiognathus nuchalis [34]. In the colo-
ial ascidian B. schlosseri, ﬁve transcripts were identiﬁed by cDNA
loning, and four of these ﬁve isolectins were effectively identi-
ed in afﬁnity chromatography preparations. B. schlosseri isolectins
BrRBLs) only differ by a few amino acids; therefore, such as ELELs,
rRBLs could not be separated by analytical techniques, such as
DS–PAGE and size exclusion chromatography [15].
ig. 7. Agglutination of bacteria by ELEL. (A) S. aureus incubated with TBS; (B) S. aureus i
cale  bars indicate 4 m.ultiple alignment among the amino acid sequence of the E. lucunter eggs lectin
-1), Stroglyocentrotus purpureos predicated RBL – domain 1 (SpRBL-1), Toxopneustes
hum salmon RBL – domain 1 (CSL-3-1).
ELEL-1 is a typical RBL since its sequence contains two typ-
ical motifs present in the most known RBLs: -ANYGR(TD)- in
N-terminal and -DPCX(G)T(Y)KY(L)- in C-terminal. The current
classiﬁcation of RBLs suggests that ELEL-1 is grouped in V-type sub-
family, because of its quaternary organization as homodimer linked
by disulﬁde bond. Besides ELEL-1, only SUEL is grouped in V-type
subfamily [3].
In our modeling, the three-dimensional structure of ELEL-1
revealed a -sandwich fold. This folding is found in two structures
of l-rhamnose-binding lectins deposited in the PDB: CSL-3 (PDB
ID: 2ZX2) [4], which was used as a template, and mouse lectin
latrophilin-1 (PDB ID: 2JXA) [35]. Interestingly, a d-rhamnose-
binding lectin, pyocin L1 of Pseudomonas aeruginosa (PDB ID: 4LED)
ncubated with ELEL. (C) E. coli incubated with TBS; (D) E. coli incubated with ELEL;
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Pig. 8. Three dimensional structure model of ELEL-1. -sandwich structure compos
36], possesses a -prism-II domain, which is different from ELEL-
, CSL-3 and latrophilin-1, indicating that the difference in the
ecognition of rhamnose conﬁgurations (d and l) by lectins can
e related to a domain that characterize their three-dimensional
tructures.
ELEL was very stable when it was submitted to a wide
ariation of pH and temperature, as expected by their high con-
ents of half-cysteine residues. Nine half-cysteines were found
n ELEL. Curiously, once ELEL was reduced (DTT) and alky-
ated (IAA) before digestions, some cysteines were not found
n its carboxyamidomethylated form, as might be expected.
or instance, peptide at m/z 955.39 corresponds to sequence
ig. 9. Molecular docking of ELEL-1 with Gb3. (A) Representation of the eletrostatic surfa
rediction of H-bonds and van der Waals interactions in the carbohydrate recognition dotwo -sheets: posterior (1, 2 and 4 strands) and frontal (3 and 5 strands).
41TKTQVCPSDGATSNVNCK58 and has a determined molecular mass
of 1908.78 Da, whereas peptide at m/z 983.93 has a determined
molecular mass of 1965.87 Da and the same sequence. The differ-
ence of 57 Da apparently results from carboxyamidomethyl missing
in one of the two cysteine residues in peptide at m/z 955.39. More-
over, other peptides were found without carboxyamidomethylated
cysteines, indicating that different cysteines have different reduc-
ing potential resulting from localization and/or neighborhood of
the residue.RBLs typically have eight cysteines paired in four disulﬁde
bonds: Cys (1)-Cys(3), Cys (2)-Cys (8), Cys (4)-Cys (7), and Cys
(5)-Cys (6) [37]. All cysteines present in ELEL are aligned with
ce area of the carbohydrate recognition domain of ELEL-1 complexed with Gb3. (B)
main. Distances in Å.
f Biolo
c
7
l
t
H
c
i
d
n
a
c
w
d
r
t
p
g
i
a
h
i
i
t
g
E
h

e
a
t
[
n
[
w
a
t
s
b
m
n
i
o
t
C
[
i
r
c
[
c
i
t
c
G
d
c
e
b
c
b
f
[
[
[
[
[
[
[R.F. Carneiro et al. / International Journal o
orresponding residues of the other RBLs, except Cys in position 7.
Cys is also present in SUEL, which, similar to ELEL, is a homodimer
inked by a disulﬁde bond [14]. Thus, 7Cys seems be involved in
he maintenance of dimers.
ELEL was not inhibited by glycoproteins, such as CSLs [11].
owever, hemagglutinating activity of ELEL was inhibited by sac-
harides with the same orientation of hydroxyl groups at C2 and C4
n the pyranose ring, such as l-rhamnose, melibiose and, to a lesser
egree, galactose. Because glucose, arabinose, l-fucose and man-
ose showed no inhibitory activity against ELEL, the conﬁguration
t C-4 is primordial for recognition.
The difference in structure between l-rhamnose and d-mannose
an be seen when comparing the symmetrical ring structures
here, in Haworth projection, the hydroxyl group at C-4 in
-mannose is below the plane of the ring (equatorial), while l-
hamnose is above it (axial). The conﬁguration at C-3 and C-5 of
he pyranose ring is also important based on the lower inhibition
otency observed for melibiose, lactose, galactose and methyl-
alactoside in comparison to l-rhamnose. The failure of GalNAc to
nhibit agglutination may  have resulted from the presence of an
cetamide group linked to C-2 of the pyranose ring. On the other
and, since galactose and -methyl galactoside showed very sim-
lar MIC  values, substituent groups in other positions, i.e., methyl
n C-1, did not affect inhibition and are, therefore, unimportant in
he binding of the sugars to the lectin. Since - or -galactosides, in
eneral, produced similar levels of inhibition, results showed that
LEL does not differentiate between them. Methyl--d-galactoside
ad the same inhibitory effect as methyl--d-galactoside, as did
-d-lactose and -d-lactose.
Several RBLs showed inhibition results similar to ELEL. For
xample, the lectins isolated from chum salmon eggs (CSL1, CSL2
nd CSL3) were inhibited by l-rhamnose, melibiose, rafﬁnose and,
o a lesser extent, galactose, but they were not inhibited by lactose
11]. BrRBLs demonstrated better inhibition by melibiose, rham-
ose and galactose, as well as rafﬁnose, but, again, to a lesser extent
15]. Like ELEL, the lectin isolated from penguin wing oyster (PPL)
as not inhibited by GalNAc. Furthermore, PPL showed a strong
fﬁnity for terminal Gal1-4GlcNAc and -lactose [12]. In contrast
o ELEL, the RBL isolated from the skin mucus of ponyﬁsh showed
trong afﬁnity for GalNAc [34], and RBLs isolated from Tribolodon
randti eggs, TBL 1 and TBL 2, were not inhibited by galactose and
elibiose, respectively [38].
Although RBLs typically recognize l-rhamnose, a few RBLs do
ot [12]. Curiously, l-rhamnose is an uncommon sugar present
n vertebrates or invertebrates, suggesting an exogenous impact
n the recognition of l-rhamnose by RBLs. Several RBLs are able
o recognize Globotriaosylceramide (Gb3: Gal1-4Gal1-4Glc1-
er). Gb3 is a common epitope located in glycolipid membrane
39,40]. Molecular simulations suggest that ELEL-1 recognizes Gb3
n a manner similar to that of CSL3. In accordance with our
esults, the amino acids involved in Gb3 recognition by ELEL-1
orrespond to the carbohydrate-binding site in CSL-3 structure
4].
Gb3 is a glycolipid antigen highly expressed in metastatic colon
ancer [41]. The interaction between ELEL and Gb3, as indicated by
n silico experiments, makes this lectin a potential tool in the iden-
iﬁcation of cancer metastasis. Indeed, RBLs can trigger apoptosis in
ell lines containing Gb3. For instance, CSL-3 showed cytotoxicity to
b3-displayng Caco-2 human colorectal adenocarcinoma cells in a
ose-dependent manner, while no effects were observed in tumor
ell lines lacking Gb3 [4]. It has been reported that RBLs also bind
ndogenously to globotriaosylceramide and that the interaction
etween RBLs and Gb3 results in the induction of proinﬂammatory
ytokines and activation of the immune system [32,42,43]. Thus,
oosting immune response seems to be an important endogenous
unction of the RBLs.
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As shown in the present study, RBLs also play an important
role in combating pathogens. More speciﬁcally, since different RBLs
can agglutinate bacterial cells, they seem to act as nonself recogni-
tion molecules [3,11,44]. The agglutination of bacterial cells most
likely results from RBL binding to lipopolysaccharides and lipotei-
choic acid, as described by Tateno and coworkers [10,29]. Like RBLs
isolated from P. penguin and B. schlosseri, ELEL was also able to
agglutinate bacterial cells. However, unlike PPL and BsRBL, ELEL
only agglutinated the Gram-positive bacterium S. aureus,  whereas
PPL agglutinated both Gram-positive and Gram-negative bacteria,
while BsRBL agglutinated only Gram-negative bacteria [12,15].
In conclusion, we isolated a Type V l-rhamnose-binding lectin
from eggs of the sea urchin E. lucunter. ELEL has carbohydrate
speciﬁcity, amino acid sequence and three-dimensional structure
similar to other rhamnose-binding lectins, characteristics which
would qualify it as a new member of the RBL superfamily. Fur-
thermore, in silico experiments suggest that ELEL recognizes Gb3
what makes this protein a potential biotechnological tool. How-
ever, future assays should be performed to evaluate the real activity
of ELEL against malignant cells.
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